help button home button Endocrine Society JCEM ENDO 08
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Re, R. N.
Right arrow Articles by Maloof, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Re, R. N.
Right arrow Articles by Maloof, F.

Journal of Clinical Endocrinology & Metabolism, Vol 43, 338-346, Copyright © 1976 by Endocrine Society


ARTICLES

The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin

RN Re, IA Kourides, EC Ridgway, BD Weintraub and F Maloof

In order to determine the mechanism by which glucocorticosteroids decrease the serum concentration of thyrotropin (TSH), we studied eight normal subjects before and after they received 16 mg of dexamethasone daily for 2 1/2 days. Serum levels of TSH and prolactin (PRL) were measured in the basal state and in response to the intravenous administration of 200 mug thyrotropin-releasing hormone (TRH); T4, free T4 (fT4), T3, and free T3 (fT3) were measured before TRH injection. Metabolic clearance rates of TSH corrected for body surface area (MCR- TSH/m2) were determined by the method of constant infusion to equilibrium; the production rates of TSH (PR-TSH/m2) were calculated. Dexamethasone produced a decrease in basal TSH from 2.2 to 0.8 muU/ml (P less than 0.02), a statistically insignificant elevation in MCR- TSH/m2 from 25.8 to 34.1 ml/min/m2, and a decrease in PR-TSH/m2 from 79 to 30 mU/day/m2 (P less than 0.01). Peak TSH response to TRH decreased from 16.4 to 5.8 muU/ml (P less than 0.005), as did TSH reserve from 1.58 to 0.54 mU - min/ml (P less than 0.005). Repetitive TRH testing alone did not account for these changes. Basal PRL, peak PRL after TRH, and PRL reserve did not change significantly after dexamethasone administration. Although Basal T4 and fT4 did not change significantly, dexamethasone did decrease T3 from 106 to 61 ng/dl (P less than 0.001) and fT3 from 174 to 76 pg/dl (P less than 0.05). Dexamethasone produced similar changes in patients with various thyroid disorders. In addition, when plasma cortisol was lowered by metyrapone administration in 25 euthyroid patients, the serum TSH concentration rose from 1.6 to 3.1 muU/ml (P less than 0.001). These data indicate that dexamethasone a) suppresses TSH secretion without increasing fT3 and fT4 and b) blunts the TSH, but not the PRL response, to TRH. Hence, one effect of the administration of dexamethasone in high dose is a direct suppression of pituitary TSH secretion. Furthermore, physiologic levesl of circulating cortisol also have a suppressive effect on serum TSH.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
J. P Brouwer, B. C Appelhof, R. P Peeters, W. J G Hoogendijk, J. Huyser, A. H Schene, J. G P Tijssen, R. Van Dyck, T. J Visser, W. M Wiersinga, et al.
Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression.
Eur. J. Endocrinol., June 1, 2006; 154(6): 819 - 825.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. L. R. Williams, S. A. Ogston, H. van Toor, T. J. Visser, R. Hume, and with collaboration from the Scottish Preterm Thyro
Serum Thyroid Hormones in Preterm Infants: Associations with Postnatal Illnesses and Drug Usage
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5954 - 5963.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. H. Canani, C. Capp, J. M. Dora, E. L. S. Meyer, M. S. Wagner, J. W. Harney, P. R. Larsen, J. L. Gross, A. C. Bianco, and A. L. Maia
The Type 2 Deiodinase A/G (Thr92Ala) Polymorphism Is Associated with Decreased Enzyme Velocity and Increased Insulin Resistance in Patients with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3472 - 3478.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
H. C. Ho, A. D. Chapital, and M. Yu
Hypothyroidism and Adrenal Insufficiency in Sepsis and Hemorrhagic Shock
Arch Surg, November 1, 2004; 139(11): 1199 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. A. Shepherdley, C. B. Daniels, S. Orgeig, S. J. Richardson, B. K. Evans, and V. M. Darras
Glucocorticoids, thyroid hormones, and iodothyronine deiodinases in embryonic saltwater crocodiles
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1155 - R1163.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Kellendonk*, S. Eiden*, O. Kretz, G. Schutz, I. Schmidt, F. Tronche, and E. Simon
Inactivation of the GR in the Nervous System Affects Energy Accumulation
Endocrinology, June 1, 2002; 143(6): 2333 - 2340.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. S. Mantzoros, M. Ozata, A. B. Negrao, M. A. Suchard, M. Ziotopoulou, S. Caglayan, R. M. Elashoff, R. J. Cogswell, P. Negro, V. Liberty, et al.
Synchronicity of Frequently Sampled Thyrotropin (TSH) and Leptin Concentrations in Healthy Adults and Leptin-Deficient Subjects: Evidence for Possible Partial TSH Regulation by Leptin in Humans
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3284 - 3291.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Korbonits, I. Bujalska, M. Shimojo, J. Nobes, S. Jordan, A. B. Grossman, and P. M. Stewart
Expression of 11{beta}-Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2728 - 2733.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. H. Samuels
Effects of Metyrapone Administration on Thyrotropin Secretion in Healthy Subjects-A Clinical Research Center Study
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3049 - 3052.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. H. Samuels
Effects of Variations in Physiological Cortisol Levels on Thyrotropin Secretion in Subjects with Adrenal Insufficiency: A Clinical Research Center Study
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1388 - 1393.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ghizzoni, G. Mastorakos, M. E. Street, A. Vottero, G. Mazzardo, M. Vanelli, G. P. Chrousos, and S. Bernasconi
Spontaneous Thyrotropin and Cortisol Secretion Interactions in Patients with Nonclassical 21-Hydroxylase Deficiency and Control Children
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3677 - 3683.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. H. Samuels and P. A. McDaniel
Thyrotropin Levels during Hydrocortisone Infusions That Mimic Fasting-Induced Cortisol Elevations: A Clinical Research Center Study
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3700 - 3704.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1976 by The Endocrine Society